Today, July 25, would be the 104th birthday of Lionel Terray. The celebrated French alpinist climbed routes from the Alps to the Himalaya to the Andes, and also wrote one of the all-time great ...

LOS ANGELES, November 17, 2025--(BUSINESS WIRE)--Terray Therapeutics, an AI-native, chemistry-first, biotech today announced its AI and experimental platform, EMMI, and the introduction of advanced ...

Success demonstrates the power of EMMI, Terray’s proprietary AI platform integrated with its rapidly expanding 13B+ target-ligand binding database and highly automated lab Terray’s EMMI platform ...

LOS ANGELES--(BUSINESS WIRE)--Terray Therapeutics, a biotechnology company improving human health by transforming the speed, cost, and success rate of small molecule drug development using computation ...

Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy $120 million series B raise for its artificial intelligence (AI) drug discovery work, and now it’s ...

In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway. By Steve Lohr Photographs by Spencer Lowell ...

Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development. New investor Bedford Ridge Capital and existing ...

Los Angeles-based Terray Therapeutics, a chemistry-first, AI-native biotechnology company, has announced the appointment of Wendy Young, Ph.D., to its Board of Directors. Terray integrates AI into ...

-- Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- FOSTER CITY, Calif. & LOS ANGELES--(BUSINESS ...

Monrovia-based biotech company Terray Therapeutics, Inc. partners with Boston-based Odyssey Therapeutics Inc. just weeks after closing a $120 million series B funding round. Brothers: Jacob and Eli ...

Terray Therapeutics has emerged with $60 million in series A funding and a mission to turbocharge drug discovery using artificial intelligence and nanotechnology. Founded in 2018, Terray is developing ...